Company · CIK 1802369
ADARx Pharmaceuticals, Inc.
| CIK | 1802369 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | ADRX (Nasdaq) |
| First annual or quarterly report | none on EDGAR |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-298782 | 2026-09-04 | 2026-09-28 | 5 |
Filings
6| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-09-28 | 424B4Final prospectus | 333-298782 | 0001193125-26-403094 |
| 2026-09-24 | EFFECTDeclared effective | 333-298782 | 9999999995-26-003052 |
| 2026-09-21 | S-1/AAmendment | 333-298782 | 0001193125-26-396007 |
| 2026-09-14 | S-1/AAmendment | 333-298782 | 0001193125-26-390724 |
| 2026-09-04 | S-1Registration filed | 333-298782 | 0001193125-26-383838 |
| 2026-06-22 | DRSDraft made public | 377-09495 | 0001193125-26-277710 |